Jai Radhakrishnan

22.9k total citations · 1 hit paper
191 papers, 9.1k citations indexed

About

Jai Radhakrishnan is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jai Radhakrishnan has authored 191 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Nephrology, 40 papers in Pulmonary and Respiratory Medicine and 34 papers in Surgery. Recurrent topics in Jai Radhakrishnan's work include Renal Diseases and Glomerulopathies (76 papers), Chronic Kidney Disease and Diabetes (30 papers) and Systemic Lupus Erythematosus Research (29 papers). Jai Radhakrishnan is often cited by papers focused on Renal Diseases and Glomerulopathies (76 papers), Chronic Kidney Disease and Diabetes (30 papers) and Systemic Lupus Erythematosus Research (29 papers). Jai Radhakrishnan collaborates with scholars based in United States, United Kingdom and Canada. Jai Radhakrishnan's co-authors include Vivette D. D’Agati, Glen S. Markowitz, Gerald B. Appel, Michael B. Stokes, Sumit Mohan, Andrew S. Bomback, Daniel Cattran, Anthony M. Valeri, Leal Herlitz and Eric Siddall and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Jai Radhakrishnan

181 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic Classification of Diabetic Nephropathy

2010 1.2k citations Jai Radhakrishnan et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Jai Radhakrishnan

Since Specialization

Citations

This map shows the geographic impact of Jai Radhakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jai Radhakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jai Radhakrishnan more than expected).

Fields of papers citing papers by Jai Radhakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jai Radhakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jai Radhakrishnan. The network helps show where Jai Radhakrishnan may publish in the future.

Co-authorship network of co-authors of Jai Radhakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Jai Radhakrishnan. A scholar is included among the top collaborators of Jai Radhakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jai Radhakrishnan. Jai Radhakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease 2024 ·British Journal of Haematology ·Divaya Bhutani, Yusha Liu, Rajshekhar Chakraborty, Jai Radhakrishnan, Suzanne Lentzsch, D. Peters, Samuel M. Rubinstein	0
2	Timing And Outcomes of Second-Line Therapy in the Era of Daratumumab-Based Frontline Therapy in Amyloidosis 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Abdul Hamid Bazarbachi, Divaya Bhutani, Jai Radhakrishnan, Markus Y. Mapara, Matthew J. Maurer, Suzanne Lentzsch, Rajshekhar Chakraborty	1
3	Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study 2024 ·Kidney International Reports ·Howard Trachtman, Jai Radhakrishnan, Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt, Hiddo J.L. Heerspink, Irene L. Noronha, Vlado Perkovic, Brad H. Rovin, Hernán Trimarchi, Muh Geot Wong, Alex Mercer, Jula K. Inrig, William E. Rote, (unknown), (unknown), (unknown), (unknown), Radko Komers	2
4	Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program 2023 ·Blood ·Rajshekhar Chakraborty, Divaya Bhutani, Markus Y. Mapara, Ran Reshef, Mathew S. Maurer, Jai Radhakrishnan, Suzanne Lentzsch	1
5	Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis 2022 ·Kidney Medicine ·Dawn J. Caster, (unknown), (unknown), (unknown), (unknown), Kirk N. Campbell, Jai Radhakrishnan, (unknown), Howard Trachtman	10
6	Strategies for Renal Protection in Cardiovascular Interventions 2022 ·Korean Circulation Journal ·Ziad A. Ali, Javier Escaned, Dariusz Dudek, Jai Radhakrishnan, Keyvan Karimi Galougahi	9
7	A pharmacist‐physician collaborative care model in chronic kidney disease 2021 ·Journal of Clinical Hypertension ·(unknown), Jai Radhakrishnan	7
8	DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS 2018 ·Journal of the American Society of Nephrology ·Howard Trachtman, Peter J. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal K. Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth V. Lieberman, Brad A. Marder, Kevin Meyers, (unknown), Jai Radhakrishnan, Tarak Srivastava, (unknown), Vladimı́r Tesař, Olga Zhdanova, Radko Komers, (unknown)	129
9	A 31-Year-Old Man With a Ring-Enhancing Brain Lesion 2017 ·Journal of Neuro-Ophthalmology ·Claire Riley, (unknown), Jacinda B. Sampson, Jai Radhakrishnan, Leal Herlitz, Ari M. Blitz, (unknown)	0
10	Drug-Induced Glomerular Disease 2015 ·Clinical Journal of the American Society of Nephrology ·Jonathan J. Hogan, Glen S. Markowitz, Jai Radhakrishnan	80
11	Rituximab treatment for fibrillary glomerulonephritis 2014 ·Nephrology Dialysis Transplantation ·John Hogan, (unknown), Pietro A. Canetta, Leal Herlitz, Jai Radhakrishnan, Gerald B. Appel, Andrew S. Bomback	36
12	Monoclonal IgG1κ Anti–Glomerular Basement Membrane Disease: A Case Report 2014 ·American Journal of Kidney Diseases ·Shana M. Coley, Shayan Shirazian, Jai Radhakrishnan, Vivette D. D’Agati	19
13	The Role of Kidney Biopsy in Heart Transplant Candidates With Kidney Disease 2010 ·Transplantation ·(unknown), (unknown), Susan Restaino, Glen S. Markowitz, Anthony M. Valeri, Jai Radhakrishnan	29
14	A 56-year-old woman with sarcoidosis and acute renal failure 2008 ·Kidney International ·(unknown), Pietro A. Canetta, Vivette D. D’Agati, Jai Radhakrishnan	11
15	Worth a Second Look 2008 ·The American Journal of Medicine ·David Goldberg, Ilan Weisberg, David Diuguid, Paul J. Gaglio, Bachir Alobeid, Scott Fink, Jai Radhakrishnan	1
16	New approaches to the treatment of glomerular diseases 2006 ·Kidney International ·Gerald B. Appel, Meryl Waldman, Jai Radhakrishnan	4
17	Sickle cell trait and gross hematuria 2006 ·Kidney International ·Krzysztof Kiryluk, (unknown), Mantu Gupta, Jai Radhakrishnan	33
18	Acute Phosphate Nephropathy following Oral Sodium Phosphate Bowel Purgative 2005 ·Journal of the American Society of Nephrology ·Glen S. Markowitz, Michael B. Stokes, Jai Radhakrishnan, Vivette D. D’Agati	251
19	Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing 2004 ·Human Pathology ·Glen S. Markowitz, Samih H. Nasr, Philip S. Klein, (unknown), (unknown), (unknown), (unknown), Jai Radhakrishnan, Vivette D. D’Agati	129
20	Antiphospholipid antibody syndrome and renal disease 2001 ·Current Opinion in Nephrology & Hypertension ·(unknown), Jai Radhakrishnan, Gerald B. Appel	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact